Pharmaceutical Technology

NOVEMBER 15, 2022

Manufacturers are actively looking at ways they can improve drug delivery through well-designed parenteral packaging systems, and the choice to deploy prefilled syringes for more and more injectable drug products is a key part of this push. Prefilled syringes offer a number of advantages over the more traditional glass vial.

Packaging 52

Packaging Vaccines Dosage Compounding 52

ISPE

NOVEMBER 22, 2022

I presented on planning and executing and designing fill lines, RABS, Isolators, and transfers – along with the differences between processing potent compounds versus non- potent compounds. Along the way – one of the things that we noticed across the industry was that most presenters at most conferences were men.

Compounding 98

Compounding Packaging Dosage Vaccines 98

The Checkup by Singlecare

SEPTEMBER 28, 2023

Other potential causes of congestion include: Stress Exposure to smoke Pollen or mold Paint fumes High blood pressure or pain medications Nasal polyps Deviated septum Enlarged adenoids (glands located behind the nasal passage) Nasal congestion due to allergies can be chronic, persisting for as long as the triggering allergen is present.

Compounding 105

Compounding Immunization Dosage Mayo Clinic 105

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. This obviously presents a huge magnitude of risk for drug developers,” he noted.

Compounding 98

Compounding Packaging Dosage Communication 98

ISPE

MARCH 8, 2023

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

The Thyroid Pharmacist

AUGUST 19, 2022

10) All three are required to be present for an autoimmune condition to manifest. pylori is present. pylori on the GI-MAP (not just what the lab showed to be positive), it ended up being 33 percent of people that had the pathogen present. MegaGuard and PyloGuard provide doses on the package. I’ve had H. pylori infection.

Health and Personal Care Stores 98

Health and Personal Care Stores Immunization Insurance Packaging 98

ISPE

SEPTEMBER 11, 2023

This article presents relevant insights on the current regulatory and technical landscape for decentralized manufacturing, with select examples of current applications, and discusses perspectives on evolving and adapting the current regulations to meet future capabilities.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52